Drawing for ACT IN

USPTO serial 79172510

ACT IN

Reviewed by CopyMark Law Group

Reg. 5010130Status 404
Filing date
Status date
Registration date
Aug 2, 2016
Examiner
BUONGIORNO, CHRISTOPHER L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ACT IN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Products for medical use, namely, agents for the treatment of tumors in the field of radiation therapy; products for medical use, namely, agents for treatment of tumors using radiation therapy; radioactive products for medical use for treatment of tumors using radiation therapy; health products, namely, pharmaceutical preparations for use in the treatment of tumors in the field of radiation therapy; radiological contrast substances for medical use in the treatment of tumors in the field of radiation therapy; chemical reagents for medical use in the treatment of tumors in the field of radiation therapy; chemical preparations for medical or pharmaceutical use in the treatment of tumors in the field of radiation therapy; drugs for medical use in the treatment of tumors in the field of radiation therapy; medicines for human medicine in the treatment of tumors in the field of radiation therapy; chemico-pharmaceutical products in the nature of chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of tumors in the field of radiation therapy; pharmaceutical products for the treatment of tumors in the field of radiation therapy; natural remedies in the realm of human medicine in the treatment of tumors in the field of radiation therapy; all these products for use in clinical studies concerning the treatment of tumors in the field of radiation therapySECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Dec 25, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 12, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Oct 23, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Oct 23, 2023INPCINVALIDATION PROCESSED—
Oct 17, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 17, 2023C71TCANCELLED SECTION 71—
Apr 7, 2017LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Jan 12, 2017LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Dec 30, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 30, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 30, 2016FIMPFINAL DISPOSITION PROCESSED—
Nov 2, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 2, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 17, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 27, 2016NPUBNOTICE OF PUBLICATION—
Apr 5, 2016CNEAEXAMINERS AMENDMENT MAILED—
Apr 5, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 5, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Apr 5, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 30, 2016LIMELIMITATION FROM THE IB - REQUEST EXAM REVIEW—
Mar 25, 2016LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Mar 17, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 17, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 17, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 9, 2015RFNTREFUSAL PROCESSED BY IB—
Sep 23, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 23, 2015RFRRREFUSAL PROCESSED BY MPU—
Sep 23, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 22, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 21, 2015RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Sep 19, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 18, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 18, 2015DOCKASSIGNED TO EXAMINER—
Sep 18, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 17, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance